{"nct_id":"NCT01798056","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy","status":"COMPLETED","status_verified_date":"2021-04","start_date":"2013-03-06","start_date_type":"ACTUAL","primary_completion_date":"2015-06-18","primary_completion_date_type":"ACTUAL","completion_date":"2016-05-20","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}